老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

LAVA Therapeutics N.V.

1.47
-0.0500-3.29%
盘后：1.470.00000.00%16:04 EDT
成交量：5.20万
成交额：7.90万
市值：3,866.88万
市盈率：-1.41
高：1.56
开：1.50
低：1.46
收：1.52
数据加载中...
总览公司新闻公告
2022/09/30

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/04/20

SEC问询函

CORRESP [Cover] - Correspondence
2022/03/24

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/05/28

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/04/08

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/04/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/03/31

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/03/31

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/03/31

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/03/24

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/03/23

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/22

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/22

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/18

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/18

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/03/10

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/02

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/02

招股说明书

F-1 - Registration statement for certain foreign private issuers